A Study of Zipalertinib and Chemotherapy Compared with Chemotherapy Alone in Patients with Advanced Non-Small-Cell Lung Cancer with Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (REZILIENT3). This evidence concerns the gene EGFR and non-small cell lung carcinoma.